A new immunomodulatory for multiple sclerosis, Myelimab, mod…
A new immunomodulatory for multiple sclerosis, Myelimab, modulates the immune system, leading to decreased demyelination. It also decreases the number of microglial cells in the brain and increases the chance of viral infection with JCV, a potentially deadly virus. Why would Myelimab increase viral infection probability?
Read DetailsA life-threatening condition cause by a severe localized or…
A life-threatening condition cause by a severe localized or system-wide infection that requires immediate attention; blood pressure drops to a dangerously low level and can begin to cause organ failure; symptoms also include paleness, chills, difficulty breathing, decreased urine output, mental confusion, and disorientation.
Read DetailsInfectious disease caused by the inhalation of bacterial spo…
Infectious disease caused by the inhalation of bacterial spores; at first, the infection seems like a mild upper respiratory tract infection such as a cold or flu, then deteriorates to severe breathing problems and shock; symptoms include fever, chills, chest discomfort, shortness of breath, cough, nausea, sweats, and headache.
Read Details